Glycemic Response in Persons With Type 2 Diabetes Mellitus
NCT ID: NCT04168541
Last Updated: 2025-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2018-02-05
2018-04-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus
NCT02856516
Glycemic Response to Oral Nutrition Supplements
NCT02612675
Glucose Response in Persons with Type 2 Diabetes
NCT04914559
Glycemic Response in Adults with Diabetes
NCT05026424
Glycemic Response in Persons with Type 2 Diabetes
NCT04413357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral Nutrition Supplement A
Product containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement
Product intake of oral nutrition supplement provided
Oral Nutrition Supplement B
Product containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement
Product intake of oral nutrition supplement provided
Oral Nutrition Supplement C
Product containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement
Product intake of oral nutrition supplement provided
Oral Nutrition Supplement D
Product containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement
Product intake of oral nutrition supplement provided
Oral Nutrition Supplement E
Product containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement
Product intake of oral nutrition supplement provided
Oral Nutrition Supplement F
Product containing calories from carbohydrate, protein, and fat
Oral Nutrition Supplement
Product intake of oral nutrition supplement provided
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral Nutrition Supplement
Product intake of oral nutrition supplement provided
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Type 2 diabetes controlled with diet or diet and metformin (Glucophage)
* Hemoglobin A1C less than 9.0%
* Fasting blood glucose less than 180 mg
* Hematocrit levels within normal limits
* Having obtained his/her informed consent
Exclusion Criteria
* Creatinine \>2.0 mg/dl
* Potassium \<3.5 mEq/l
* Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting
* Currently unstable diabetes or under treatment for cancer, heart disease, renal disease
* Unable to give informed consent or follow instructions
* Current insulin therapy or insulin therapy within the past month
* Patient who are pregnant
* Allergies to milk, soy or any component of the test product
* Patient who in the investigators assessment cannot be expected to comply with treatment
* Currently participating or having participated in another clinical trial
* Patients with anemia
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joel Neutel, MD
Role: PRINCIPAL_INVESTIGATOR
Orange County Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orange County Research Center
Tustin, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17.11.US.HCN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.